Biomarkers Associated with Regorafenib First-Line Treatment Benefits in Metastatic Colorectal Cancer Patients: REFRAME Molecular Study.
Cancers
Conde, Elisa E; Earl, Julie J; Crespo-Toro, Lorena L; Blanco-Agudo, Carolina C; Ramos-Muñoz, Edurne E; Rodríguez-Serrano, E Macarena EM; Martínez Ávila, Jose Carlos JC; Salinas-Muñoz, Laura L; Serrano-Huertas, Silvia S; Ferreiro, Reyes R; Rodriguez-Garrote, Mercedes M; Sainz, Bruno B; Massuti, Bartomeu B; Alfonso, Pilar García PG; Benavides, Manuel M; Aranda, Enrique E; García-Bermejo, María Laura ML; Carrato, Alfredo A
Combination of variations in inflammation- and endoplasmic reticulum-associated genes as putative biomarker for bevacizumab response in KRAS wild-type colorectal cancer.
Scientific Reports
Barat, Ana A; Smeets, Dominiek D; Moran, Bruce B; Zhang, Wu W; Cao, Shu S; Das, Sudipto S; Klinger, Rut R; Betge, Johannes J; Murphy, Verena V; Bacon, Orna O; Kay, Elaine W EW; Van Grieken, Nicole C T NCT; Verheul, Henk M W HMW; Gaiser, Timo T; Schulte, Nadine N; Ebert, Matthias P MP; Fender, Bozena B; Hennessy, Bryan T BT; McNamara, Deborah A DA; O'Connor, Darran D; Gallagher, William M WM; Cremolini, Chiara C; Loupakis, Fotios F; Parikh, Aparna A; Mancao, Christoph C; Ylstra, Bauke B; Lambrechts, Diether D; Lenz, Heinz-Josef HJ; Byrne, Annette T AT; Prehn, Jochen H M JHM